CISTERO 50MG INJECTION

About

Cistero 50mg Injection contains Cisplatin, a platinum-based chemotherapy agent widely used in the treatment of various solid tumors. Cisplatin exerts its cytotoxic effects by forming cross-links in DNA, which inhibits DNA synthesis and repair, ultimately leading to apoptosis of cancer cells. It is a cell cycle non-specific agent, meaning it can kill cells at any stage of the cell cycle. Its potent antineoplastic activity makes it a cornerstone in many combination chemotherapy regimens, particularly for highly aggressive cancers.

Due to its significant side effect profile, including severe nephrotoxicity, ototoxicity, and emetogenicity, Cisplatin administration requires careful patient selection, extensive pre-hydration, and antiemetic prophylaxis. It is always administered intravenously under strict medical supervision in a hospital setting. Regular monitoring of renal function, electrolytes, and audiometry is essential throughout the treatment course to manage and mitigate potential toxicities.

Uses

• Testicular cancer
• Ovarian cancer
• Bladder cancer
• Head and neck cancer

Directions For Use

This medicine is administered intravenously by a qualified healthcare professional.

Pre-hydration and antiemetic medication are typically given before administration.

Benefits

• Highly effective in treating several solid tumors
• Curative potential in germ cell tumors
• Often used as a cornerstone in combination regimens
• Can achieve significant tumor response
• Established efficacy in various cancer types
• Contributes to improved survival outcomes

Side Effects

• Severe nausea and vomiting
• Nephrotoxicity (kidney damage)
• Ototoxicity (hearing loss, tinnitus)
• Myelosuppression (low blood counts)
• Peripheral neuropathy (nerve damage)
• Electrolyte disturbances (hypomagnesemia, hypokalemia)
• Hypersensitivity reactions
• Alopecia (hair loss)
• Fatigue and weakness
• Anorexia (loss of appetite)
• Stomatitis (mouth sores)
• Hepatotoxicity (liver damage)

Safety Measures

• Alcohol - Avoid alcohol consumption during treatment with Cistero 50mg Injection as it may exacerbate side effects, particularly nausea and liver toxicity.
• Pregnancy - Cistero 50mg Injection is contraindicated in pregnancy due to its severe teratogenic and embryotoxic effects. Effective contraception is mandatory for both male and female patients during and for a period after treatment.
• Breastfeeding - Breastfeeding is contraindicated during treatment with Cistero 50mg Injection due to the potential for serious adverse reactions in the breastfed infant.
• Liver - Use with caution in patients with hepatic impairment. Liver function should be monitored, and dose adjustments may be considered.
• Kidney - Cistero 50mg Injection is highly nephrotoxic. It is contraindicated in severe renal impairment and requires careful monitoring of kidney function with extensive hydration in all patients.
• Lung - Rare cases of pulmonary fibrosis have been reported. Monitor for new or worsening respiratory symptoms, especially with prolonged use.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.